Organogenesis Holdings Inc.

IPO

Regenerative Tissue Innovations | Organogenesis

Public · Canton, United States · Founded 1985 · $50.0M raised

Employees
501–1000
Founded
1985
Business Model
B2B
Total Funding
$50.0M
Last Round
$20.0M Venture RoundMay 2017
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Regenerative medicine company developing and manufacturing advanced wound care, surgery, and sports medicine products.

Summary

Organogenesis Holdings Inc. is a Biotech company based in Canton, United States, founded in 1985. It has raised $50.0M in total across 2 rounds, most recently a $20.0M Venture Round in May 2017. Investors include Avista Capital Partners and Eastward Capital Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

SPAC MergerSPAC MergerAug 2018

Sign up to see all 3 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Organogenesis Holdings Inc. on Indexed.vc
<a href="https://indexed.vc/companies/organogenesis-holdings-inc"><img src="https://indexed.vc/api/badge/company/organogenesis-holdings-inc" alt="Organogenesis Holdings Inc. on Indexed.vc" width="260" height="76" /></a>